Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique

Enrolling by invitation

Conditions studied: GASTROINTESTINAL NEOPLASMS

In brief

The goal of this observational study intends to explore the evolution trend and related factors of postoperative reflux of esophageal cancer based on PEPTEST detection, in order to identify postoperative reflux The main question it aims to answer are: to provide evidence for high-risk groups, improvement of surgical methods for esophageal cancer, and development of health education programs to prevent postoperative reflux. Using convenient sampling method, patients undergoing esophagectomy in thoracic surgery Department of Cancer Hospital of Chinese Academy of Medical Sciences from January 1, 2023 were continuously enrolled. PEPTEST was performed once before surgery, before discharge, 1 month, 3 months, and 6 months after surgery. The incidence of pathological reflux at 5 time points before and after surgery was observed and compared (that is, both T-line and C-line were shown). The trend of pepsin content in saliva before and after operation; The relationship between pathological reflux and surgical factors; The relationship between pathological reflux and life habits after operation; Relationship between pathological regurgitation and demographic characteristics.

Key facts

Study ID

NCT06509022

Run by

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

People needed

138

Starts

2024-03-01

Expected to finish

2026-12-01

Last updated by the study team

2026-04-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who were pathologically diagnosed with esophageal cancer and underwent esophagectomy for esophageal cancer.
• The patient can communicate in Mandarin.
• Those who can come to the hospital for review on time.

You may not qualify if…

• People with cognitive impairment or mental illness.
• Complicating other serious life-threatening diseases (such as leukemia or autoimmune diseases).
• Unwilling to participate in the study.

Where it is running

• Cancer Institute and Hospital, Chinese Academy of Medical Sciences — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.